Trial Profile
Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Selegiline (Primary) ; Metamfetamine
- Indications Alzheimer's disease; Attention-deficit hyperactivity disorder; Cognition disorders; Depression; Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- 06 Jan 2007 New trial record.